GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis.

Overview of attention for article published in Molecular Cancer Therapeutics, May 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 10 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 14 X posts from 10 X users, with an upper bound of 11,110 followers.

RT @MCT_AACR: Attending the session on The #OvarianCancer Microenvironment at #AACR23? Read MCT article "GAS6-AXL Inhibition by AVB-500 Ove…

17 Apr 2023

Reply Repost Favourite

Attending the session on The #OvarianCancer Microenvironment at #AACR23? Read MCT article "GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis" by Katherine C. Fuh. https://t.co/Wh5wAC

17 Apr 2023

Reply Repost Favourite

RT @sbrucemd: I’m so grateful for @KatherineFuh’s amazing mentorship! Thesis ✅ And my first featured article! @MCT_AACR @WashU_OBGYN https:…

30 Aug 2022

Reply Repost Favourite

RT @KatherineFuh: Congrats @sbrucemd on such great work!! Can’t wait to see this through as a clinical trial. Collaborating with the fab me…

29 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 10 additional X posts.